Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Gain readies for Phase 1b trial of Parkinson’s therapy GT-02287
Parkinson’s News Today
Related Posts
Post navigation
Previous Post
Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference
Latest Articles
Clear Filters
February 28, 2024
Swiss biotech restores motor function in mice with Parkinson’s disease
Read More
August 30, 2023
Gain Therapeutics: Tackling Rare Diseases at the Genetic Level
Read More
July 2, 2024
Gain’s clinical GDP1 Parkinson’s drug helps mice retain cognitive function
Read More
Close
